Alzamend Neuro Inc

Alzamend Neuro Inc Stock

—P/E
€10.07MMarket capitalisation
-US$2.40Earnings
—Dividend yield

Current price

—
1D
1W
1M
3M
6M
1Y
3Y
Max

Company description

Alzamend Neuro Inc is an early clinical-stage biopharmaceutical company. It is focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders, including Alzheimer's. Its mission is to developand market safe and effective treatments. The company's pipeline consists of two novel therapeutic drug candidates, AL001 - a patented ionic cocrystal technology delivering lithium via a therapeutic combination of lithium, proline and salicylate, and AL002 - a patented method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine that seeks to restore the ability of a patient's immunological system to combat Alzheimer's.

Alzamend Neuro Inc is registered in the following country: United States of America (Exchange: USNASD).

Key metrics

Key metrics and master data for the Alzamend Neuro Inc stock.

Market capitalisation
€10.07M
P/E
—
P/B
-113.64
P/S
—
P/CF
-1.36
Issued shares 97M Units

Return

Here you can see the performance of the Alzamend Neuro Inc stock.

PeriodPerfor­mance
1 Week-32.43 %
1 Month-42.92 %
3 Months-69.88 %
6 Months-73.40 %
1 Year-88.88 %
YTD-75.58 %

Dividends

With an (expected) annual dividend of —, the current stock price results in a dividend yield of —.

Dividend type—
(Expected) annual dividend —
Dividend yield —

Splits

The table shows the splits of the Alzamend Neuro Inc share.

DateRatio
No data available.

Which ETF contains the Alzamend Neuro Inc stock?

The Alzamend Neuro Inc stock is contained in a total of 0 ETFs with at least 1%. You can find a list of these ETFs in the following table. With —, Alzamend Neuro Inc has the largest weight in .

Name
Weighting
Region
Country
TER
Replication
Volume (£m)

Frequently asked questions

Here you can find all answers to your questions about the Alzamend Neuro Inc stock.

Master data is provided by Morningstar (stocks, ETFs, funds), CoinGecko (cryptocurrencies) and Isarvest GmbH. Price data is at least 15-minute delayed exchange prices (stocks, ETFs, funds) or NAV prices (ETFs, funds). Real-time prices – where available – are provided by the providers and Lang & Schwarz (stocks, ETFs, funds) and CoinGecko (cryptocurrencies).

Isarvest GmbH assumes no liability for the information presented and cannot guarantee that the data is complete and accurate.

Affiliate notice *
Links marked with an asterisk (*) are advertising or affiliate links. If you purchase or sign up through this link, we receive compensation from the provider. This comes at no additional cost or disadvantage to you. We use this revenue to fund our free services. Thank you for your support.